PHILADELPHIA, October 12, 2010 /PRNewswire/ -- Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The American Journal of Pathology (AJP) in partnership with the American Society for Investigative Pathology (ASIP).
The American Journal of Pathology is the official publication of the American Society for Investigative Pathology. Under the guidance of Editor-in-Chief Michael P. Lisanti, MD, PhD, Thomas Jefferson University, Philadelphia, PA, AJP is a monthly, peer-reviewed, scholarly publication that reports cutting-edge science which advances basic and translational knowledge of disease pathogenesis, classification, and diagnosis, as well as basic biological mechanisms relating to disease. It is the leading global forum for reporting quality original research on cellular and molecular mechanisms of disease. Articles include studies on human disease and relevant experimental models using cellular, molecular, animal, biological, chemical, and immunological approaches in conjunction with morphology.
Elsevier is truly honored to partner with the American Society for Investigative Pathology to publish The American Journal of Pathology. This premier journal represents the highest-quality research, covering a broad range of topics and specialties. As such, the fit with our current publishing program is excellent, states Andrew Berin, Publishing Director, Elsevier.
Dr. Mark E. Sobel, ASIP's Executive Officer, states, ASIP looks forward to its partnership with Elsevier, which will serve to further the Society's mission of disseminating high-quality research and information about the cellular and molecular mechanisms of disease. We are confident that Elsevier's expertise, innovative technology, and global presence will serve to expand the reach and impact of our flagship journal, The American Journal of Pathology.
About The American Society for Investigative Pathology (ASIP)
The American Society for Investigative Pathology is an educational professional not-for-profit society dedicated to the discovery, advancement, and dissemination of basic and translational knowledge in experimental pathology and related disciplines. This is achieved by fostering investigation into the pathogenesis, classification, diagnosis, and manifestations of disease through meetings, publications, and educational activities. Investigative pathology is an integrative discipline that links the presentation of disease in the whole organism to its fundamental cellular and molecular mechanisms, using a variety of structural, functional, and genetic techniques and ultimately applies research findings to the diagnosis and treatment of diseases. ASIP advocates for the practice of investigative pathology and fosters the professional career development and education of its members. For more information, please visit: http://www.asip.org
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com/) and Cell 9http://www.cell.com/), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (http://www.sciencedirect.com/), SciVerse Scopus (http://www.scopus.com/home.url), Reaxys ( http://notice.reaxys.com/maintenance.html), MD Consult ( http://www.mdconsult.com/php/222075573-2/homepage) and Nursing Consult (http://www.nursingconsult.com/php/222075595-2/home.html), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com/) and MEDai's Pinpoint Review (http://www.medai.com/), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com/wps/find/homepage.cws_home) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC ( http://www.reedelsevier.com/Pages/Home.aspx), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media Contact Andrew Berin Publishing Director, Elsevier +1-212-633-3887 a.berin@elsevier.com http://ajp.amjpathol.org/ http://jmd.amjpathol.org/
SOURCE: Elsevier
CONTACT: Media Contact: Andrew Berin, Publishing Director, Elsevier,+1-212-633-3887, a.berin@elsevier.com
Comments